W.A.I.T. Indicator

Diverse group of people sitting together in hospital waiting room

Latin American patients must wait an average of 4.7 years to access innovative or cutting-edge treatments

DALL·E 2024-08-28 11.29.03 - A realistic and photographic image of advanced medical treatments. The image shows a close-up of various medical items representing innovative medicat

Reliance: homologación regulatoria para acelerar el acceso a medicamentos 

pexels-julie-viken-593451

What is the waiting time to access new cancer medications in Latin America?

Smiling Cancer Patient Looking at test results

FIFARMA launches the second version of the W.A.I.T. Indicator Survey measuring the waiting time to access innovative drugs in LATAM

pexels-daniel-frank-305565

WAIT Indicator: responsible pragmatism in measuring access to new technologies in Latin America

Search

Recent posts

man-working-as-pharmacist
Good Regulatory Practices: principles that transform global health
Portada-blog afuera
Bruno Costa Gabriel: nuevo Presidente del Consejo Directivo de FIFARMA
G20_2024_banner_at_the_Rio_de_Janeiro_municipal_prefecture_building
Statement on the Rio de Janiero Declaration of the G20 Health Ministers